Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06100172 · ClinicalTrials.gov registry record · NA

Transcutaneous Auricular Neurostimulation After Lumbar Surgery

A NA study of Pain, Postoperative and Opioid Use, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06100172: Recruiting NA study of Pain, Postoperative and Opioid Use, sponsored by University of Texas Southwestern Medical Center.

NCT06100172 is a NA study of Pain, Postoperative and Opioid Use that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 20 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06100172, a NA study of Pain, Postoperative and Opioid Use, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study, entitled "Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery", is to demonstrate whether transcutaneous auricular neurostimulation (tAN) can non-invasively reduce the perception of pain in patients undergoing lumbar surgery. tAN is placed on and around the ear to non-invasively stimulate branches of the vagus and trigeminal nerves and modulate specific brain regions associated with pain.

Primary Outcome

Patients will be asked to report their level of pain using the Visual Analog Scale. Possible scores for VAS pain scale ranges from 0-10 where 0="no pain" to 10="severe pain"

Interventions

  • DEVICE Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)
  • DEVICE Sham Control Device

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-10-29
Est. Completion 2027-12
Phase NA

What NCT06100172 shows while recruiting

NCT06100172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) is the first listed.

NCT06100172 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06100172 about?

NCT06100172 is a clinical study titled "Transcutaneous Auricular Neurostimulation After Lumbar Surgery". The purpose of this study, entitled "Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery", is to demonstrate whether transcutaneous auricular neurostimulation (tAN) can non-invasively reduce the perception of pa...

What is the current status of trial NCT06100172?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-10-29. Estimated completion is 2027-12.

What conditions does trial NCT06100172 study?

This clinical trial studies the following conditions: Pain, Postoperative, Opioid Use, Lumbar Spine Injury.

What interventions are being tested in trial NCT06100172?

The interventions under investigation include: Sparrow Ascent Transcutaneous Auricular Neurostimulation (tAN) (DEVICE), Sham Control Device (DEVICE).

Who is sponsoring clinical trial NCT06100172?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06100172 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06100172's enrollment target sits among peer trials

20 110th of 113 higher than 4 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06100172, the US trial registry maintained by the National Library of Medicine. NCT06100172 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.